Pharmaceuticals announced that the U.S. FDA has accepted the New Drug Application for investigational plozasiran for the ...
The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback